AT369364T
Heterocyclic tripeptides as hepatitis c inhibitors
Abstract
This invention is on (1) compounds: which R1 is hydroxy or sulfonic n amine derivatives; R2 is tert--butyl or-CH2-C (CH3) 3 or-CH2-ring e base; R3 is tert--butyl or ring himself base and the R4 is ring butyl, ring e base or ring himself base; or its drug Shang can accept of salt, its available for HCV NS3 protease of inhibitor.
Term
Term ended
Expired 24 January 2023, 3.7 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
43 members in 30 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 2369970 | Canada | A |
Members43
| Document | Office | Kind | |
|---|---|---|---|
| CA2369970A1 | Canada | A1 | |
| CA2474031A1 | Canada | A1 | |
| WO03064416A1 | World Intellectual Property Organization (WIPO) | A1 | |
| UY27638A1 | Uruguay | A1 | |
| US2003186895A1 | United States of America | A1 | |
| US2003191067A1 | United States of America | A1 | |
| PE20030854A1 | Peru | A1 | |
| TW200307680A | Taiwan Province of China | A | |
| NO20043642L | Norway | L | |
| KR20040081167A | Republic of Korea | A | |
| ECSP045224A | Ecuador | A | |
| MXPA04007446A | Mexico | A | |
| EP1474423A1 | European Patent Office (EPO) | A1 | |
| BR0307517A | Brazil | A | |
| AR038382A1 | Argentina | A1 | |
| EA200400986A1 | Eurasian Patent Organization (EAPO) | A1 | |
| PL371283A1 | Poland | A1 | |
| HRP20040696A2 | Croatia | A2 | |
| CN1642951A | China | A | |
| JP2005529069A | Japan | A | |
| NZ534730A | New Zealand | A | |
| CO5611112A2 | Colombia | A2 | |
| HK1078870A1 | Hong Kong, China | A1 | |
| ZA200406014B | South Africa | B | |
| US7091184B2 | United States of America | B2 | |
| RS67104A | Serbia | A | |
| EA007739B1 | Eurasian Patent Organization (EAPO) | B1 | |
| UA77757C2 | Ukraine | C2 | |
| TWI274056B | Taiwan Province of China | B | |
| SA03240006B1 | Saudi Arabia | B1 | |
| SA1728B1 | Saudi Arabia | B1 | |
| CN1304416C | China | C | |
| EP1474423B1 | European Patent Office (EPO) | B1 | |
| AT369364TThis record | Austria | T | |
| ATE369364T1 | Austria | T1 | |
| DE60315420D1 | Germany | D1 | |
| MY133719A | Malaysia | A | |
| AU2003202348B2 | Australia | B2 | |
| ES2290425T3 | Spain | T3 | |
| JP4073872B2 | Japan | B2 | |
| DE60315420T2 | Germany | T2 | |
| NO326421B1 | Norway | B1 | |
| CA2474031C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 3700745
Titles2
- German
- HETEROCYCLISCHE TRIPEPTIDE ALS HEPATITIS C- INHIBITOREN
- English
- Heterocyclic tripeptides as hepatitis C inhibitors
Classification
- CPC, 10
- C07D417/14
- A61K38/00
- A61P1/16
- C07K5/0808
- A61P31/00
- C07K5/0812
- A61P31/12
- C07K5/0827
- A61P31/14
- A61K31/47
- IPC, 13
- C07D417 14
- C12N15 09
- A61K31 47
- A61K31 7056
- A61K38 00
- A61K38 21
- A61P1 16
- A61P31 00
- A61P31 14
- C07K4 00
- C07K5 08
- C07K5 083
- C07K5 087